Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 6541-6550 of 12127

Page
per page
  1. N-Methylnicotinamide
    C6682 N-Methylnicotinamide
      ≥25.1 mg/mL
  2. MS023
    B6183 MS023
     1 Citation
    Summary: type I PRMTs inhibitor
      ≥28.7 mg/mL
  3. Guvacoline (hydrobromide)
    C3017 Guvacoline (hydrobromide)
    Summary: full agonist of atrial and ileal muscarinic receptors
      ≤1 mg/mL
  4. (S)-SLV 319
    C3568 (S)-SLV 319
    Summary: CB1 receptor antagonist
      ≤30 mg/mL
  5. IWP-2-V2
    C3625 IWP-2-V2
    Summary: Wnt production inhibitor
      ≤2 mg/mL
  6. Bafilomycin C1
    C4729 Bafilomycin C1
    Summary: vacuolar H+-ATPases (V-ATPases) inhibitor
      Soluble in ethanol;Soluble in methanol;Soluble in DMSO;Soluble in dimethyl formamide
  7. Darglitazone
    C4758 Darglitazone
    Summary: PPARγ agonist with antidiabetic actions
      ≤5 mg/mL
  8. p-nitro-Cyclic Pifithrin-α
    C5104 p-nitro-Cyclic Pifithrin-α
    Summary: inactivator of p53
      ≤1 mg/mL
  9. ML-291
    C5358 ML-291
    Summary: apoptosis inducer
      ≥43 mg/mL
  10. Mutant EGFR inhibitor
    B1103 Mutant EGFR inhibitor
    Summary: Selective Mutated EGFR inhibitor
      Soluble in DMSO

Items 6541-6550 of 12127

Page
per page